- Research article
- Open Access
Revised Mimivirus major capsid protein sequence reveals intron-containing gene structure and extra domain
© Azza et al; licensee BioMed Central Ltd. 2009
Received: 09 July 2008
Accepted: 11 May 2009
Published: 11 May 2009
Acanthamoebae polyphaga Mimivirus (APM) is the largest known dsDNA virus. The viral particle has a nearly icosahedral structure with an internal capsid shell surrounded with a dense layer of fibrils. A Capsid protein sequence, D13L, was deduced from the APM L425 coding gene and was shown to be the most abundant protein found within the viral particle. However this protein remained poorly characterised until now. A revised protein sequence deposited in a database suggested an additional N-terminal stretch of 142 amino acids missing from the original deduced sequence. This result led us to investigate the L425 gene structure and the biochemical properties of the complete APM major Capsid protein.
This study describes the full length 3430 bp Capsid coding gene and characterises the 593 amino acids long corresponding Capsid protein 1. The recombinant full length protein allowed the production of a specific monoclonal antibody able to detect the Capsid protein 1 within the viral particle. This protein appeared to be post-translationnally modified by glycosylation and phosphorylation. We proposed a secondary structure prediction of APM Capsid protein 1 compared to the Capsid protein structure of Paramecium Bursaria Chlorella Virus 1, another member of the Nucleo-Cytoplasmic Large DNA virus family.
The characterisation of the full length L425 Capsid coding gene of Acanthamoebae polyphaga Mimivirus provides new insights into the structure of the main Capsid protein. The production of a full length recombinant protein will be useful for further structural studies.
Acanthamoebae polyphaga Mimivirus was described for the first time in 2003 . It was isolated from amoebae growing in water sample from a cooling tower during an outbreak of pneumonia in an English hospital. Compared to other members of the Nucleo-Cytoplasmic Large DNA Viruses (NCLDV) family , APM has very particular characteristics due to its size, structure, genome sequence , and replication cycle through a specific virus factory . The virus particle was shown to be icosahedral, with a capsid shell diameter of 5000 Å covered by long fibers and appears to have at least two lipid membranes beneath its Capsid protein . The APM 1.2-Mb genome encodes at least 911 proteins [Genbank: NC_006450] . Proteomic analysis of proteins extracted from purified viral particles allowed the identification of 114 proteins including the Capsid protein D13L, coded by the L425 gene. The D13L Capsid protein was shown to be the most abundant and major glycoprotein of APM  and is thought to be the main component of the outermost protein shell layer. The protein sequence was deduced from the first available Methionine codon in the L425 open reading frame. Recently, based on mass spectrometry analysis of the Capsid protein D13L peptides, the original protein sequence was revised and completed with 142 supplementary N-terminal amino-acids (AA) [UniProtKB: Q5UQL7]  and thereafter named here Capsid protein 1. The aim of this study was to characterize the full length APM Capsid protein 1 coding gene and to provide new insights into the structure of the protein. Blast of the Capsid protein 1 coding sequence on the APM genome sequence revealed that the start codon might be located 2042 bp upstream from the start codon of the previously annotated L425 coding gene. We produced a recombinant full length Capsid protein 1 and specific monoclonal antibodies (mAb) that might be useful to develop further structural analysis or detection assays.
cDNA cloning and sequencing
Total RNA from uninfected or APM infected A. polyphaga was extracted using RNeasy extraction kit (Qiagen) as previously described . The Capsid protein 1 cDNA was synthsesized from APM infected A. polyphaga RNA by using the Superscript One-Step RT-PCR with Platinum Taq kit (Invitrogen) with the following primers:
Q5UQL7NcoIF: 5'-GAAGGAGATATACCATGGCAGGTGGTTTACTCCAATTA-3' and Q5UQL7SmaIR: 5'-GATGAGAACCCCCCCCGGGATTACTGTACGCTAATCCG-3'. Underlined are the APM L425 gene specific sequences: nt 560 926 – 560 449 for the forward primer; nt 557 533 – 557 515 for the reverse primer. The resulting 1782 bp cDNA fragment was then cloned into the pIVEX 2.3 expression vector (Roche) at the NcoI and SmaI sites. Recombinant plasmids were selected, purified and then incorporated into the d-Rhodamine Terminator Cycle Sequencing Ready Reaction buffer kit with Amplitaq Polymerase FS (Applied Biosystems). Reaction products were resolved by using an ABI 3100 automated sequencer and sequence analysis was performed using the software package ABI Prism DNA Sequencing Analysis Software version 3.0 (Applied Biosystems). T7 promoter and T7 terminator primers were used as well as two primer pairs targeting internal regions of the cDNA: QUQL7-SF1: 5'-GCTGGCAGTAGTAATTCTGC-3'; QUQL7-SR1: 5'-GCAGAATTACTACTGCCAGC-3'; and QU5QL7-SF2: 5'-GAAGGTAATGATGGTAGAAG-3'; QU5QL7-SR2: 5'-CTTCTACCATCATTACCTTC-3'.
RNA was extracted from uninfected or APM-infected amoebae at 0, 2, 4, 8 and 16 hours post infection. 100 ng of each RNA was submitted to RT-PCR amplification using the SuperScript One-Step RT-PCR kit (Invitrogen) with the Q5UQL7NcoIF/Q5UQL7SmaIR primer pair. cDNA synthesis was performed in one cycle of 30 minutes at 50°C, 3 minutes at 94°C and subsequent PCR reaction with 35 cycles of 30 seconds at 94°C, 30 seconds at 60°C, 30 seconds at 72°C, and one cycle of 10 minutes at 72°C. Amplified products were analysed by electrophoresis on 1% agarose gel. GeneRuler 1 kb DNA ladder (MBI-Fermentas) was used as a DNA size marker.
Expression of the recombinant Capsid protein 1
Expression of the Capsid protein 1 was performed using a cell-free translation system , the High Yield RTS 500 Escherichia coli Circular Template kit (Rapid Translation System, Roche). Reactions were performed at 30°C for 24 h, with a stirrer speed of 120 rpm, with 15 μg of recombinant plasmid used as DNA template. The RTS sample was then centrifuged for 10 min at 10 000 rpm and the pellet was resuspended in Laemmli buffer, heated for 5 min at 95°C, resolved by 7.5% SDS-PAGE, followed by Coomassie blue staining or transfer onto nitrocellulose membrane for immunoblot analysis using a anti-Histidine monoclonal antibody. The recombinant Capsid protein 1 was extracted from polyacrylamide gels by the electroelution method using the ElutaTube™ Protein Extraction Kit (Fermentas Life Sciences) according to the manufacturer's protocol and used to immunise mice for the production of monoclonal antibodies.
Monoclonal antibodies production
Three six week-old female BALB/c mice were inoculated three times intraperitoneally at 14-days interval with 2 μg electroeluted protein mixed with 400 μg aluminium hydroxide and 10 μg CpG as previously described . Four days after the last immunisation, spleen cells fusion was performed with X63.Ag 8.653 myeloma cells (2:1) using 50% 1500 polyethylene glycol (Roche). Cells were grown in RPMI medium (Invitrogen) with 15% heat inactivated fetal calf serum (Invitrogen) and hypoxanthine-aminopterin-thymidine selective medium (Invitrogen) at 37°C with 5% CO2. Hybridoma supernatants were screened 10 days after by ELISA using plates coated overnight with 10 μg/ml of APM extract in sodium carbonate buffer 100 mM, pH 9.6. Positive hybridomas were subcloned by limiting dilution and submitted to isotyping using a mouse monoclonal isotyping kit (Sigma-Aldrich). Hybridomas producing the highest mAb titers were then subcloned, expanded, and tested by Western blot analysis using APM extract subjected to 2D gel electrophoresis and transferred onto nitrocellulose.
APM particles were purified through a 25% sucrose gradient and APM extract was prepared for 2-D gel electrophoresis as previously reported . Immobiline™ DryStrips (7 cm, pH 3–10 GE Healthcare) were rehydrated overnight using 125 μl rehydration buffer [8 M urea, 2% (w/v) CHAPS, 60 mM DTT, 0,5% (v/v) IPG buffer (GE Healthcare)] containing 20 μg of solubilized APM proteins and IEF was carried out according to the manufacturer's protocol (IPGphor II, GE Healthcare). Before the second dimension electrophoresis was performed, strips were equilibrated twice in 5 ml equilibration buffer [30% (v/v) glycerol, 3% (w/v) SDS, 6 M urea, 50 mM Tris-HCl, bromophenol blue, pH 8.8] for 15 min. This buffer was supplemented with 65 mM DTT for the first equilibration and with 100 mM iodoacetamide for the second one. The strips were then embedded in 0.5% agarose and the proteins resolved by 10% SDS-PAGE (Mini-Protean III, Bio-Rad). Gels were stained either with silver or transferred onto nitrocellulose for Western blot analysis using Capsid protein 1 specific mAb; anti-Phosphothreonine, anti-Phosphotyrosine or anti-Phosphoserine (10-4 dilution, Sigma) mAbs; or rabbit polyclonal antiserum anti-methylated Lysine (dilution 4.10-2, Biomol GmbH). The detection of glycosylated proteins in 2D gels was performed according to the Pro-Q Emeral 300 glycoprotein stain kit's procedure (Invitrogen) and visualized using a 300 nm UV illuminator.
Results and discussion
Based on this sequence, outermost 5'- and 3'-terminal primers, Q5UQL7NcoIF and Q5UQL7SmaIR respectively, were designed to determine the Capsid protein 1 gene structure. RNA was extracted from APM-infected A. polyphaga and used to synthetise full length L425 cDNA. We then cloned the full-length cDNA into an expression vector and sequenced the target gene. Comparison of the cDNA sequence (1782 bp) with the APM genomic DNA sequence confirmed that the Capsid protein 1 gene is 3430 bp long and consists of three exons interrupted by two introns (Figure 1A). This result supposed that splicing events might occur during gene transcription and/or RNA maturation. To gain insight into this possibility, RT-PCR analyses were performed on RNA extracted at different time from APM-infected A. polyphaga using the Q5UQL7NcoIF/Q5UQL7SmaIR primer pair (Figure 1B). Agarose gel electrophoresis showed a fragment, about 4000 bp long, amplified from APM genomic DNA (lane 1), and a fragment, about 1800 bp long, from infected cell RNA (lanes 3–7), while no fragment was amplified from uninfected cell RNA (lane 2). Only fully spliced mRNA was detected from t0 to t16 p.i., with an increased signal. No precursor RNA could be identified. Detection of Capsid protein 1 mRNA as soon as t0 was not surprising since this RNA was shown to be packaged within the viral particle . Additional RT-PCR experiments performed using primer pairs able to detect the potential different forms of spliced Capsid protein 1 RNA were unsuccessful to demonstrate alternative forms of spliced RNA whatever the time post-infection (data not shown).
Due to an erroneous gene model prediction, the coding sequence for L425 was wrongly assigned and was until now only partially described . The full length coding gene appeared to be composed of three exons separated by two untranscribed introns. This leads to the synthesis of a full length 593AA protein translated from a spliced RNA. This feature seems to be unique to APM since the PBCV1 A383R or the ASFV B646L capsid coding genes do not contain intron sequence [20, 21]. Tentative bioinformatics analyses of the APM L425 gene introns provided poor informations about their sequences. Intron 1 (nt 560868 – 559 680) matched with an evalue of 1e-4 to group I introns while being not related to a specific subgroup [22, 23]. Intron 2 (nt 559 659 – 559 232) did not show significant match with either group I or group II introns . Until now, the only other described introns in APM genome are self-splicing introns present in the coding sequences of the two largest RNA polymerase subunits coding genes L244 and R501 .
Rabbit or mouse immune sera produced against purified APM particles were unable to recognize the Capsid protein as an antigen in intact viruses, most probably due to the presence of a dense layer of fibrils surrounding the capsid shell. The availability of a monoclonal antibody against Capsid protein 1 might be useful for the development of detection assays in clinical samples since APM might represent a novel human pathogen [24–26].
APM Capsid protein 1 is a glycosylated protein. However its sequence contained no signal peptide, which makes the potential glycosylation sites unlikely to be exposed to the cellular glycosylation machinery. Post-translation modifications might occur in the virus factory since viral proteins appeared to be synthesised herein [3, 4]. It might be thought that APM possibly use alternative pathways for translation and post-translational modifications. Metabolic studies on APM infected amoebae will contribute to understanding the complex interactions between host and pathogen. The recombinant full length Capsid protein might also represent a helpful tool to determine the structural organisation of APM viral capsid.
Annotation of APM genome revealed 1262 putative ORFs of length = 100 amino acid residues. 911ORFs were predicted to be protein coding genes and 298 of them had functional attributes . Description of the full length Capsid coding gene and characterisation of the corresponding protein demonstrated that structural and functional studies will contribute to improve our knowledge of gene composition and expression of such a complex genome.
This work was funded by CNRS. The authors would acknowledge the technical assistance of Claude Nappez for mice immunisation and preparation of monoclonal antibodies and of Gregory Gimenez for bioinformatics analysis.
- La Scola B, Audic S, Robert C, Jungang L, de Lamballerie X, Drancourt M, Birtles R, Claverie JM, Raoult D: A giant virus in amoebae. Science. 2003, 299: 2033- 10.1126/science.1081867View ArticlePubMedGoogle Scholar
- Iyer LM, Aravind L, Koonin EV: Common origin of four diverse families of large eukaryotic DNA viruses. J Virol. 2001, 75: 11720-11734. 10.1128/JVI.75.23.11720-11734.2001PubMed CentralView ArticlePubMedGoogle Scholar
- Raoult D, Audic S, Robert C, Abergel C, Renesto P, Ogata H, La Scola B, Suzan M, Claverie JM: The 1.2-megabase genome sequence of Mimivirus. Science. 2004, 306: 1344-1350. 10.1126/science.1101485View ArticlePubMedGoogle Scholar
- Suzan-Monti M, La Scola B, Barrassi L, Espinosa L, Raoult D: Ultrastructural characterization of the giant volcano-like virus factory of Acanthamoeba polyphaga Mimivirus. PLoS ONE. 2007, 2: e328- 10.1371/journal.pone.0000328PubMed CentralView ArticlePubMedGoogle Scholar
- Xiao C, Chipman PR, Battisti AJ, Bowman VD, Renesto P, Raoult D, Rossmann MG: Cryo-electron microscopy of the giant Mimivirus. J Mol Biol. 2005, 353: 493-496. 10.1016/j.jmb.2005.08.060View ArticlePubMedGoogle Scholar
- Genbank. http://www.ncbi.nlm.nih.gov/sites/entrez?db=genome&cmd=search&term=NC_006450
- Renesto P, Abergel C, Decloquement P, Moinier D, Azza S, Ogata H, Fourquet P, Gorvel JP, Claverie JM: Mimivirus giant particles incorporate a large fraction of anonymous and unique gene products. J Virol. 2006, 80: 11678-11685. 10.1128/JVI.00940-06PubMed CentralView ArticlePubMedGoogle Scholar
- UniProtKB. http://www.uniprot.org/uniprot/Q5UQL7
- Spirin AS, Baranov VI, Ryabova LA, Ovodov SY, Alakhov YB: A continuous cell-free translation system capable of producing polypeptides in high yield. Science. 1988, 242: 1162-1164. 10.1126/science.3055301View ArticlePubMedGoogle Scholar
- Near K, Stowers AW, Jankovic D, Kaslow DC: Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminium hydroxide in a murine malaria vaccine model. Infect Immun. 2002, 70: 692-701. 10.1128/IAI.70.2.692-701.2002PubMed CentralView ArticlePubMedGoogle Scholar
- TBLASTN. http://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Translations&PROGRAM=tblastn&BLAST_PROGRAMS=tblastn&PAGE_TYPE=BlastSearch&SHOW_DEFAULTS=on
- ExPASy proteomics server. http://www.cbs.dtu.dk/services/
- Van Etten JL: Unusual life style of giant Chlorella viruses. Ann Rev Genet. 2003, 37: 153-195. 10.1146/annurev.genet.37.110801.143915View ArticlePubMedGoogle Scholar
- Benson SD, Bamford JK, Bamford DH, Burnett RM: Does common architecture reveal a viral lineage spanning all three domains of life?. Mol Cell. 2004, 16: 673-685. 10.1016/j.molcel.2004.11.016View ArticlePubMedGoogle Scholar
- RCSB Protein Data Bank. http://www.rcsb.org/pdb/explore/explore.do?structureId=1J5Q
- PSIPRED protein structure prediction server. http://bioinf.cs.ucl.ac.uk/psipred/
- Jones DT: Protein secondary structure prediction based on position-specific scoring matrices. J Mol Biol. 1999, 292: 195-202. 10.1006/jmbi.1999.3091View ArticlePubMedGoogle Scholar
- McGuffin LJ, Bryson K, Jones DT: The PSIPRED protein structure prediction server. Bioinformatics. 2000, 16: 404-405. 10.1093/bioinformatics/16.4.404View ArticlePubMedGoogle Scholar
- Nandhagopal N, Simpson AA, Gurnon JR, Yan X, Baker TS, Graves MV, Van Etten JL, Rossmann MG: The structure and evolution of the major capsid protein of a large, lipid-containing DNA virus. Proc Natl Acad Sci USA. 2002, 99: 14758-14763. 10.1073/pnas.232580699PubMed CentralView ArticlePubMedGoogle Scholar
- Kutish GF, Li Y, Lu Z, Furuta M, Rock DL, Van Etten JL: Analysis of 76 kb of the Chlorella Virus PBCV-1 330-kb Genome: Map Positions 182 to 258. Virology. 1996, 223: 303-307. 10.1006/viro.1996.0482View ArticlePubMedGoogle Scholar
- Yáñez RJ, Rodriguez JM, Nogal ML, Yuste L, Enriquez C, Rodriguez JF, Viñuela E: Analysis of the complete nucleotide sequence of African Swine Fever virus. Virology. 1995, 208: 249-278. 10.1006/viro.1995.1149View ArticlePubMedGoogle Scholar
- Griffiths-Jones S, Moxon S, Marshall M, Khanna A, Eddy SR, Bateman A: Rfam: annotating non-coding RNAs in complete genomes. Nucleic Acids Research. 2005, 33: D121-D124. 10.1093/nar/gki081PubMed CentralView ArticlePubMedGoogle Scholar
- Zhou Y, Lu C, Wu QJ, Wang Y, Sun ZT, Deng JC, Zhang Y: GISSD: Group I Intron Sequence and Structure Database. Nucleic Acids Research. 2008, D31-D37. 36 Database,Google Scholar
- Berger P, Papazian L, Drancourt M, La Scola B, Auffray JP, Raoult D: Ameba-associated microorganisms and diagnosis of nosocomial pneumonia. Emerg Infect Dis. 2006, 12: 248-255.PubMed CentralView ArticlePubMedGoogle Scholar
- La Scola B, Marrie TJ, Auffray JP, Raoult D: Mimivirus in pneumonia patients. Emerg Infect Dis. 2005, 11: 449-452.PubMed CentralView ArticlePubMedGoogle Scholar
- Raoult D, Renesto P, Brouqui P: Laboratory infection of a technician by Mimivirus. Ann Intern Med. 2006, 144: 702-703.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.